Merck's , Covid Antiviral Pill, Approved by UK Regulator.<br />Merck's antiviral pill was found <br />to be effective at treating COVID-19 and was <br />approved by Britain’s medicines regulator.<br />Merck's antiviral pill was found <br />to be effective at treating COVID-19 and was <br />approved by Britain’s medicines regulator.<br />The treatment, called molnupiravir, was found to be , “safe and effective at reducing the risk of hospitalisation <br />and death in people with mild to moderate COVID-19 who <br />are at increased risk of developing severe disease.” .<br />Britain is the first country to approve <br />the drug, which NBC reports could be <br />a game-changer in the fight against Covid.<br />Britain is the first country to approve <br />the drug, which NBC reports could be <br />a game-changer in the fight against Covid.<br />The pill was developed by Ridgeback Biotherapeutics and Merck. .<br />According to NBC, <br />the pill prohibits the virus from multiplying <br />and reduces the severity of the disease.<br />The MHRA said the decision , “follows a rigorous review of its safety, <br />quality and effectiveness.”.<br />According to a clinical study, the oral pill <br />should be taken during the early stages of Covid <br />infection to be the most effective.<br />The pill has been authorized for use with those with mild to moderate Covid and are at risk for developing severe illness.<br />The pill has been authorized for use with those with mild to moderate Covid and are at risk for developing severe illness.<br />Those factors include anyone over the age of 60, obesity, diabetes and heart disease. .<br />According to NBC, the U.S. <br />Food and Drug Administration is scheduled <br />to begin evaluation of the the pill on November 30.<br />The FDA's advisory committee will then decide to approve the antiviral for emergency use authorization in the U.S
